Devazepide increases food intake in male but not female Zucker rats

Physiology and Behavior

Volumn 60, Issue 1, 1996, Pages 273-275

  Strohmayer, Alan J ^a,c   Greenberg, Danielle ^b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c Center for Neuropsychological Services   (United States)

Author keywords

CCK; CCK antagonists; Gender; Genetic obesity; Ingestion; Satiety; Sex differences

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ RECEPTOR; DEVAZEPIDE;

ANIMAL; ARTICLE; BODY WEIGHT; CALORIC INTAKE; DRUG EFFECT; EATING; FEMALE; MALE; PHYSIOLOGY; PSYCHOPHYSIOLOGY; RAT; SEX DIFFERENCE; ZUCKER RAT;

ANIMALS; BENZODIAZEPINONES; BODY WEIGHT; CHOLECYSTOKININ; DEVAZEPIDE; EATING; ENERGY INTAKE; FEMALE; MALE; RATS; RATS, ZUCKER; RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, CHOLECYSTOKININ; SATIETY RESPONSE; SEX FACTORS;

EID: 0030184597     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/0031-9384(96)83164-7     Document Type: Article

References (34)

1. 125I-cholecystokinin octapeptide binding in the ventromedial hypothalamic nucleus. Neuroendocrinology 45:257-262; 1987.
2. Becker, E. E.; Grinker, J. A. Meal patterns in the genetically obese rat. Physiol. Behav. 18:685-692; 1977.
3. Bray, G. A.; Saiduddin, S.; York, D. A.; Serdloff, R. S. Effect of estradiol on uterine weight, thyroid function, food intake, and pituitary weight of genetically obese (fatty-Zucker) and lean rats (39486). Proc. Soc. Exp. Biol. Med. 153:88-91; 1976.
4. Bray, G. A.; York, D. A. Hypothalamic and genetic obesity in experimental animals: An autonomic and endocrine hypothesis. Physiol. Rev. 59:719-809; 1979.
5. Bray, G. A.; York, D. A.; Fisler, J. S. Experimental obesity: A homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system. Vitam. Horm. 45:1-125; 1989.
6. Butera, P. C.; Bradway, D. M.; Cataldo, N. J. Modulation of the satiety effect of cholecystokinin by estradiol. Physiol. Behav. 53:1235-1238; 1993.
7. Castonguay, T. W.; Hartman, W. J.; Fitzpatrick, E. A.; Satern, J. S. Meal patterns in the genetically obese Zucker rat: A reexamination. Physiol. Behav. 28:911-916; 1982.
8. A receptors. Eur. J. Pharmacol. 173:233-234; 1989.
9. B) receptors. Science 245:1509-1511; 1989.
10. Dulawa, S. C.; VanderWeele, D. A. Cholecystokinin and estradiol synergistically potentiate satiety in rats. Peptides 15(5):913-918; 1994.
11. Ebenezer, I. S.; de la Riva, C.; Baldwin, B. A. Effects of the CCK receptor antagonist MK-329 on food intake in pigs. Physiol. Behav. 47:145-148; 1990.
12. Geary, N.; Trace, D.; McEwen, B.; Smith, G. P. Cyclic estradiol replacement increases the satiety effect of CCK-8 in ovariectomized rats. Physiol. Behav. 56(2):281-289; 1994.
13. Gibbs, J.; Geary, N.; Smith, G. P. Peptide signals for satiety. In: Moody, T. W., ed. Growth factors, peptides, and receptors. New York: Plenum Press; 1993:435-443.
14. Gibbs, J.; Smith, G. P. Effects of brain-out peptides on satiety. In: Bjorntorp, P.; Brodoff, B., eds. Obesity. Philadelphia, PA: J. B. Lippincott, Co.; 1992:399-410.
15. Hewson, G.; Leighton, G. E.; Hill, R. G.; Hughes, J. The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin. Br. J. Pharmacol. 93:79-84; 1988.
16. Kava, R.; West, D. B.; Lukasik, V. A.; et al. The effects of gonadectomy on glucose tolerance of genetically obese (fa/fa) rats: Influence of sex and genetic background. Int. J. Obes. 16:103-111; 1991.
17. McLaughlin, C. L.; Baile, C. A. Decreased sensitivity of Zucker obese and lean rats to the putative satiety agent cholecystokinin. Physiol. Behav. 25:543-548; 1980.
18. McLaughlin, C. L.; Baile, C. A. Feeding and drinking behavior responses of adult Zucker obese rats to cholecystokinin. Physiol. Behav. 25:535-541; 1980.
19. Melville, L. D.; Smith, G. P.; Gibbs, J. Devazepide antagonizes the inhibitory effect of cholecystokinin on intake in sham-feeding rats. Pharmacol. Biochem. Behav. 43:975-977; 1992.
20. A-receptor antagonist increases food intake in rats. Am. J. Physiol. 262:R216-R219; 1992.
21. O'Neill, M. F.; Kitchener, S. J.; Dourish, C. T.; Iversen, S. D. The CCK antagonists devazepide and L-365,260 promote weight gain in weanling rats. Br. J. Pharmacol. 99:137P; 1990.
22. Reidelberger, R. D.; O'Rourke, M. F. Potent cholecystokinin antagonist L-364,718 stimulates food intake in rats. Am. J. Physiol. 257:R1512-R1518; 1989.
23. Schneider, L. H.; Murphy, R. B.; Gibbs, J.; Smith, G. P. Comparative potencies of CCK antagonists for the reversal of the satiating effect of cholecystokinin. In: Wang, R. Y.; Schoenfeld, R., eds. Cholecystokinin antagonists. New York: Alan R. Liss, Inc.; 1988:263-284.
24. Silverman, M.; Bank, S.; Lendvai, S. The cholecystokinin receptor antagonist, L-364,718 increases food consumption. Dig. Dis. Sci. 32:1188; 1987.
25. Smith, G. P.; Gibbs, J.; Schneider, L.; et al. The satiating effect of cholecystokinin. In: Oomura, Y.; Tarui, S.; Inoue, S.; Shimazu, T., eds. Progress in obesity research. London: John Libbey & Company, Ltd.; 1991:25-28.
26. Smith, G. P.; Tyrka, A.; Gibbs, J. Type-A CCK receptors mediate the inhibition of food intake and activity by CCK-8 in 9-to 12-day old rat pups. Pharmacol. Biochem. Behav. 38:207-210; 1991.
27. Strohmayer, A.; von Heyn, R.; Dornstein, L.; Greenberg, D. CCK receptor blockade by L-364,718 increases food intake and meal taking behavior in lean but not obese Zucker rats. Appetite 12:240; 1989.
28. Strohmayer, A. J.; Greenberg, D. Devazepide alters meal patterns in lean, but not obese male Zucker rats. Physiol. Behav. 56:1037-1039; 1994.
29. Strohmayer, A. J.; Smith, G. P. Cholecystokinin inhibits food-intake in genetically obese (C57BL-6J-ob) mice. Peptides 2:39-32; 1981.
30. Strohmayer, A. J.; Smith, G. P. A sex difference in the effect of CCK-8 on food and water intake in obese (ob/ob) and lean (+/+) mice. Peptides 8(5):845-848; 1987.
31. Wade, G. N.; Schneider, J. E. Metabolic fuels and reproduction in female mammals. Neurosci. Behav. Rev. 16:235-272; 1992.
32. Wager-Srdar, S. A.; Gannon, M.; Levine, A. S. The effect of cholecystokinin on food intake in gonadectomized and intact rats: The influence of sex hormones. Physiol. Behav. 40:25-28; 1987.
33. Watson, C. A.; Schneider, L. H.; Corp, E. S.; Weatherford, S. C.; Shindledecker, R.; Murphy, R. B.; Smith, G. P.; Gibbs, J. The effects of chronic and acute treatment with the potent peripheral cholecystokinin antagonist L-364,718 on food and water intake in the rat. Soc. Neurosci. Abstr. 14:1196; 1988.
34. Wolkowitz, O. M.; Gertz, B.; Weingartner, H.; Beccaria, L.; Thompson, K.; Liddle, R. A. Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist. Biol. Psychiatry 28:169-173; 1990.